![L. Edwards](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
L. Edwards
No open positions remaining
Net worth: 2 M $ as of 2026-07-30
Profile
Mr. L.
T.
Edwards is a Chief Commercial Officer & Executive VP at Arcutis Biotherapeutics, Inc. Mr. Edwards was previously employed as a Vice President & Head-Immunology Business by Incyte Corp.
and a Vice President-Immunology by UCB, Inc. He received his undergraduate degree from East Tennessee State University and an MBA from Embry-Riddle Aeronautical University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-07 | 59,928 ( 0.05% ) | 2 M $ | 2026-07-30 |
Former positions of L. Edwards
| Companies | Position | End |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2026-08-20 |
| INCYTE CORPORATION | Corporate Officer/Principal | - |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
Training of L. Edwards
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
East Tennessee State University
 East Tennessee State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Embry-Riddle Aeronautical University
 Embry-Riddle Aeronautical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
- Stock Market
- Insiders
- L. Edwards
